AnaptysBio Inc (ANAB)
26.33
+0.34
(+1.31%)
USD |
NASDAQ |
May 02, 12:02
AnaptysBio Market Cap: 704.67M for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 01, 2024 | 695.57M |
| April 30, 2024 | 651.41M |
| April 29, 2024 | 570.05M |
| April 26, 2024 | 562.03M |
| April 25, 2024 | 505.02M |
| April 24, 2024 | 515.72M |
| April 23, 2024 | 513.32M |
| April 22, 2024 | 526.16M |
| April 19, 2024 | 531.78M |
| April 18, 2024 | 530.71M |
| April 17, 2024 | 574.60M |
| April 16, 2024 | 571.12M |
| April 15, 2024 | 569.25M |
| April 12, 2024 | 607.79M |
| April 11, 2024 | 661.85M |
| April 10, 2024 | 593.34M |
| April 09, 2024 | 576.21M |
| April 08, 2024 | 553.19M |
| April 05, 2024 | 564.17M |
| April 04, 2024 | 570.05M |
| April 03, 2024 | 554.53M |
| April 02, 2024 | 557.74M |
| April 01, 2024 | 570.59M |
| March 28, 2024 | 602.70M |
| March 27, 2024 | 572.20M |
| Date | Value |
|---|---|
| March 26, 2024 | 578.08M |
| March 25, 2024 | 564.70M |
| March 22, 2024 | 579.96M |
| March 21, 2024 | 654.36M |
| March 20, 2024 | 640.71M |
| March 19, 2024 | 622.78M |
| March 18, 2024 | 620.10M |
| March 15, 2024 | 627.59M |
| March 14, 2024 | 631.61M |
| March 13, 2024 | 660.78M |
| March 12, 2024 | 697.45M |
| March 11, 2024 | 624.92M |
| March 08, 2024 | 663.72M |
| March 07, 2024 | 659.18M |
| March 06, 2024 | 682.19M |
| March 05, 2024 | 677.91M |
| March 04, 2024 | 695.51M |
| March 01, 2024 | 676.89M |
| February 29, 2024 | 679.02M |
| February 28, 2024 | 686.47M |
| February 27, 2024 | 704.02M |
| February 26, 2024 | 703.76M |
| February 23, 2024 | 688.06M |
| February 22, 2024 | 672.37M |
| February 21, 2024 | 677.96M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
276.22M
Minimum
Nov 08 2019
2.101B
Maximum
May 29 2019
704.96M
Average
644.62M
Median
Market Cap Benchmarks
| XOMA Corp | 300.18M |
| Fate Therapeutics Inc | 400.92M |
| Ocular Therapeutix Inc | 832.31M |
| Apellis Pharmaceuticals Inc | 5.690B |
| Stoke Therapeutics Inc | 547.31M |
Market Cap Related Metrics
| PS Ratio | 41.32 |
| PEG Ratio | -0.1311 |
| Price to Book Value | 7.998 |
| Price | 26.33 |
| Earnings Yield | -23.09% |
| PEGY Ratio | -0.1311 |